Treatment of lobular breast cancer
A Westminster Hall debate on the treatment of lobular breast cancer is scheduled for Tuesday 10 December 2024 at 2.30pm. The debate will be led by Helen Hayes MP.
This House of Commons Debate Pack briefing has been prepared in anticipation of the debate entitled “Access and waiting time standards for early intervention in psychosis.” This debate is sponsored by Norman Lamb MP and will take place in Westminster Hall on Thursday 15th March 2018 at 1.30pm.
Access and waiting time standards for early intervention in psychosis (315 KB , PDF)
This Debate Pack provides background information, parliamentary material, press articles, and further reading suggestions which Members may find useful in preparation for this debate.
Since April 2016, the Government and NHS England have been committed to the standard that 50% of people, aged 14-65, experiencing a first episode of psychosis should have access to a care package, which conforms to NICE clinical guidelines and quality standards, within two weeks of referral, with a target that this should rise to at least 60% by 2020/21.
In January 2018, Norman Lamb MP published a report, Discrimination at the Heart of the NHS, which argued that, while the waiting time aspect of the standard was being met, there were concerns about whether the Government had focused sufficiently on whether the provision of a NICE-approved package of treatment was being adhered to.
This Debate Pack covers the policy background to the introduction of this standard, including the Government’s commitment to “parity of esteem” between mental and physical health, and provides statistics on early intervention in psychosis waiting times.
Access and waiting time standards for early intervention in psychosis (315 KB , PDF)
A Westminster Hall debate on the treatment of lobular breast cancer is scheduled for Tuesday 10 December 2024 at 2.30pm. The debate will be led by Helen Hayes MP.
A debate has been scheduled in the Commons Chamber for 12 December on a motion on the performance of the Medicines and healthcare products regulatory agency. The subject for the debate has been chosen by the Backbench Business Committee.
Find out how to make complaints about NHS care and treatment in England.